What is Autologous NK Cell Therapy?

What is Autologous NK Cell Therapy?

What are Natural Killer Cells? +1(844) 4NK-CELLПодробнее

What are Natural Killer Cells? +1(844) 4NK-CELL

Current research into NK cell therapy and the potential for use in other conditionsПодробнее

Current research into NK cell therapy and the potential for use in other conditions

Enhanced NK-cells in stage 4 sarcoma treatmentПодробнее

Enhanced NK-cells in stage 4 sarcoma treatment

CAR-T Cells. Cancer Immunotherapy with Prof. Dr. William MurphyПодробнее

CAR-T Cells. Cancer Immunotherapy with Prof. Dr. William Murphy

First-in-human study of autologous memory-like NK cells in patients with MRD+ multiple myelomaПодробнее

First-in-human study of autologous memory-like NK cells in patients with MRD+ multiple myeloma

NK Cells in Neuroinflammation: Potential Therapeutic Role for Autism - Paul Song MD @Synchrony2022Подробнее

NK Cells in Neuroinflammation: Potential Therapeutic Role for Autism - Paul Song MD @Synchrony2022

Optimism for NK cell therapy as a future Alzheimer’s disease treatmentПодробнее

Optimism for NK cell therapy as a future Alzheimer’s disease treatment

VII Workshop LIM/31 HC-FMUSP: NK Cell-based Cancer ImmunotherapyПодробнее

VII Workshop LIM/31 HC-FMUSP: NK Cell-based Cancer Immunotherapy

PNK-007: allogeneic NK-cell product post-ASCT in MMПодробнее

PNK-007: allogeneic NK-cell product post-ASCT in MM

Professor Katy Rezvani - CAR-NK therapyПодробнее

Professor Katy Rezvani - CAR-NK therapy

Role of CAR T Therapy in Treatment Strategies - Ravi Vij, MD | MCRT Webcast October 31 (8/10)Подробнее

Role of CAR T Therapy in Treatment Strategies - Ravi Vij, MD | MCRT Webcast October 31 (8/10)

Cell Therapy for Allogeneic Stem Cell Transplant by Dr Richard ChamplinПодробнее

Cell Therapy for Allogeneic Stem Cell Transplant by Dr Richard Champlin

NextGenNK update ATMP Sweden 2020Подробнее

NextGenNK update ATMP Sweden 2020

Chimeric Antigen Receptors: From proof of concept to widely applicable clinical research solutionsПодробнее

Chimeric Antigen Receptors: From proof of concept to widely applicable clinical research solutions